Blood test breakthrough? new study aims to spot rare cancers earlier

NCT ID NCT06361641

First seen Jun 24, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This study looks at a type of immune cell called monocytes in people with certain blood cancers (polycythemia vera, essential thrombocythemia, and myelofibrosis). Researchers will analyze blood samples from 70 newly diagnosed patients to find unique patterns in these cells. The goal is to see if these patterns can help confirm the diagnosis more accurately than current methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a new blood test that helps doctors diagnose these blood cancers more accurately and earlier.
What could go wrong
This is an early observational study with only 70 participants, so results may not apply to everyone. It is not testing a treatment, so it won't directly help patients yet.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL THROMBOCYTHEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BESCOND Charles

    NOT_YET_RECRUITING

    Cholet, Maine et Loire, 49325, France

  • GOUBAND Agathe

    RECRUITING

    Angers, Maine et Loire, 49933, France

  • TRUCHAN-GRACZYK Malgorzata

    NOT_YET_RECRUITING

    Saumur, Maine et Loire, 49400, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.